{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T19:12:53Z","timestamp":1776107573291,"version":"3.50.1"},"reference-count":29,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2017,2,16]],"date-time":"2017-02-16T00:00:00Z","timestamp":1487203200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Nephrology"],"published-print":{"date-parts":[[2017,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Aims<\/jats:title><jats:p>Cyclosporin A (CsA) is considered as an effective treatment option for steroid\u2010resistant or\u2010dependent patients with adult\u2010onset minimal change disease (MCD). However, CsA resistance or dependence is also observed in these patients. Tacrolimus (TAC) is a calcineurin inhibitor that is potent in cytokine suppression. The authors aim to evaluate the efficacy and safety of TAC therapy in CsA\u2010resistant and\u2010dependent adult\u2010onset MCD patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Patients with adult\u2010onset MCD were enrolled in our department from 2008 to 2012. All patients were demonstrated to be resistant to or dependent on CsA therapy. Prednisone (0.5\u00a0mg\/kg per day) combined with TAC (0.05\u20130.1\u00a0mg\/kg per day) were prescribed to these patients for at least 6\u00a0months. The primary outcome was complete or partial remission of proteinuria. Secondary outcomes included time required for complete or partial remission, adverse events, number of relapses, and TAC dosages.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 11 MCD patients were enrolled in this observational study. The numbers of patients who presented with resistance to or dependence on CsA were 7 and 4, respectively. The total remission rate was 90.9% (10\/11) with the complete remission rate 72.7% (8\/11). Most remission patients achieved remission during the first 2\u00a0months of TAC therapy. Patients who presented with dependence on CsA had achieved complete remission with TAC therapy, while outcomes for CsA\u2010resistant patients were four complete remissions, two partial remissions and one resistance. The adverse events were observed in this study included infection, diarrhoea, and worsened hypertension. Five patients who had remission experienced relapse.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Tacrolimus improves proteinuria remission in adults with CsA\u2010resistant or \u2010dependent MCD.<\/jats:p><\/jats:sec>","DOI":"10.1111\/nep.12991","type":"journal-article","created":{"date-parts":[[2016,12,30]],"date-time":"2016-12-30T06:02:41Z","timestamp":1483077761000},"page":"251-256","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Tacrolimus improves proteinuria remission in adults with cyclosporine A\u2010resistant or \u2010dependent minimal change disease"],"prefix":"10.1111","volume":"22","author":[{"given":"Dechao","family":"Xu","sequence":"first","affiliation":[{"name":"Kidney Institute of PLA, Department of Nephrology, Shanghai Changzheng Hospital Second Military Medical University  Shanghai China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang","family":"Gao","sequence":"additional","affiliation":[{"name":"Kidney Institute of PLA, Department of Nephrology, Shanghai Changzheng Hospital Second Military Medical University  Shanghai China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rongrong","family":"Bian","sequence":"additional","affiliation":[{"name":"Kidney Institute of PLA, Department of Nephrology, Shanghai Changzheng Hospital Second Military Medical University  Shanghai China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changlin","family":"Mei","sequence":"additional","affiliation":[{"name":"Kidney Institute of PLA, Department of Nephrology, Shanghai Changzheng Hospital Second Military Medical University  Shanghai China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenggang","family":"Xu","sequence":"additional","affiliation":[{"name":"Kidney Institute of PLA, Department of Nephrology, Shanghai Changzheng Hospital Second Military Medical University  Shanghai China"},{"name":"Department of Nephrology, Third affiliated Hospital Second Military Medical University  Shanghai China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2017,2,16]]},"reference":[{"key":"e_1_2_5_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(97)90485-6"},{"key":"e_1_2_5_3_1","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1681\/ASN.V85824","article-title":"Treatment of the idiopathic nephrotic syndrome: regimens and outcomes in children and adults","volume":"8","author":"Tune BM","year":"1997","journal-title":"J. Am. Soc. Nephrol."},{"key":"e_1_2_5_4_1","doi-asserted-by":"publisher","DOI":"10.1159\/000046215"},{"key":"e_1_2_5_5_1","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.03531006"},{"key":"e_1_2_5_6_1","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2012070734"},{"key":"e_1_2_5_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcb.2010.09.011"},{"key":"e_1_2_5_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-3046.2010.01437.x"},{"key":"e_1_2_5_9_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfm688"},{"key":"e_1_2_5_10_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfi274"},{"key":"e_1_2_5_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2012.03.008"},{"key":"e_1_2_5_12_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfm637"},{"key":"e_1_2_5_13_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/17.4.655"},{"key":"e_1_2_5_14_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/12.11.2433"},{"key":"e_1_2_5_15_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5002553"},{"key":"e_1_2_5_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajkd.2003.07.011"},{"key":"e_1_2_5_17_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2009.02.018"},{"key":"e_1_2_5_18_1","doi-asserted-by":"publisher","DOI":"10.2174\/092986711794088407"},{"key":"e_1_2_5_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)07493-5"},{"key":"e_1_2_5_20_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm.1857"},{"key":"e_1_2_5_21_1","doi-asserted-by":"publisher","DOI":"10.1159\/000337175"},{"key":"e_1_2_5_22_1","doi-asserted-by":"publisher","DOI":"10.1210\/me.2011-0029"},{"key":"e_1_2_5_23_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0106164"},{"key":"e_1_2_5_24_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2261"},{"key":"e_1_2_5_25_1","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.4049\/jimmunol.148.4.1049","article-title":"Cyclosporin A and FK506 mediate differential effects on T cell activation in vivo","volume":"148","author":"Bishop DK","year":"1992","journal-title":"J. Immunol."},{"key":"e_1_2_5_26_1","first-page":"2920","article-title":"FK 506, rapamycin, and cyclosporine: effects on IL\u20104 and IL\u201010 mRNA levels in a T\u2010helper 2 cell line","volume":"23","author":"Wang SC","year":"1991","journal-title":"Transpl P"},{"key":"e_1_2_5_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)62731-6"},{"key":"e_1_2_5_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/nep.12351"},{"key":"e_1_2_5_29_1","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2013.1446"},{"key":"e_1_2_5_30_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gft207"}],"container-title":["Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fnep.12991","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/nep.12991","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T19:40:11Z","timestamp":1696275611000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/nep.12991"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,16]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["10.1111\/nep.12991"],"URL":"https:\/\/doi.org\/10.1111\/nep.12991","archive":["Portico"],"relation":{},"ISSN":["1320-5358","1440-1797"],"issn-type":[{"value":"1320-5358","type":"print"},{"value":"1440-1797","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,16]]},"assertion":[{"value":"2017-02-16","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}